Projects
Search from 1171 projects:
1171 Project(s)
ETATUS: Eye Tracking as an Assistance Tool in Ultrasound Training
Jan 1, 2025
Fundamental Research - Jan 1, 2025 - Dec 31, 2025
Ongoing
Project leader: Bektas Kenan
Members: Ostendorp Carsten
PROtective ventilation with FLOW–controlled ventilation to improve postoperative pulmonary outcome after ROBOT–assisted laparoscopic surgery – an international multicenter pilot randomized clinical trial.
Dec 31, 2024In einer internationalen, multizentrischen, randomisierten klinischen Pilotstudie wird die intraoperative flusskontrollierte Beatmung (FCV) mit der druckkontrollierten Beatmung (PCV) bei Patienten verglichen, die für eine roboterassistierte laparosko...
Clinical Studies - Dec 31, 2024 - Mar 31, 2025
Scheduled
Project leader: Yurttas Timur, Lüdi Markus
Role of thyreoidectomy for the treatment of amiodarone induced thyrotoxicosis: a retrospective cohort study
Dec 20, 2024
Clinical Studies - Dec 20, 2024 - Dec 31, 2025
Ongoing
Project leader: Koster Markus, Bilz Stefan
Members: Clerici Thomas, Kolb Walter, Uthayanan Ushanthan, Brenner Roman
ETOP 25-23 ADOPT-lung
Dec 6, 2024An international, multicentre, open-label randomised phase III trial to evaluate the benefit of adding adjuvant durvalumab after neoadjuvant chemotherapy plus durvalumab in patients with stage IIB-IIIB (N2) resectable NSCLC
Clinical Studies - Dec 6, 2024 - Dec 31, 2029
Ongoing
Project leader: Früh Martin
Members: Harder Anja, Müller Fiona
Assessment of Torque Teno Virus (TTV) viral load as marker for baseline immunity in healthcare workers
Dec 2, 2024This project will retrospectively assess the association of SARS-CoV-2 vaccination status with TTV viral loads in a cohort of healthcare workers and correlation with susceptibility to respiratory infections, determined by total number of influenza-li...
Clinical Studies - Dec 2, 2024 - Oct 31, 2025
Scheduled
Project leader: Kohler Philipp
Members: Kuster Stefan, Kahlert Christian, Grässli Fabian
SWISS TAVI
Nov 4, 2024Prospective, National, Multi-Center Registry of Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI) in Switzerland (SwissTAVI)
Register - Nov 4, 2024 - Dec 30, 2040
Ongoing
Members: Haager Philipp, Vetsch Susanne, Maeder Micha
Colchicine in Patients at Cardiac Risk undergoing Major Non-Cardiac Surgery: prospective, randomized, triple-blinded, placebo-controlled, multi-centre study
Nov 1, 2024
Clinical Studies - Nov 1, 2024 - Sep 30, 2027
Scheduled
Project leader: Filipovic Miodrag, Yurttas Timur
Members: Klein Carsten, Keller Mirja
Major adverse cardiovascular events in cancer patients during and after treatment with immune checkpoint inhibitors
Nov 1, 2024
Clinical Studies - Nov 1, 2024 - Oct 31, 2027
Scheduled
Project leader: Daetwyler Eveline
Members: Scheler Eva, Kuster Gabriela M, Zippelius Alfred, Rothschild Sacha I
Addition of Darolutamide to first line treatment of mCRPC: a randomized open label phase II trial.
Oct 31, 2024
Clinical Studies - Oct 31, 2024 - Dec 31, 2028
Ongoing
Project leader: Fischer Stefanie
Members: Dei Cas Alissa
Deciphering the significance of the ErbB receptor family in metastatic cutaneous squamous cell carcinoma
Oct 30, 2024
Clinical Studies - Oct 30, 2024 - Dec 31, 2025
Ongoing
Project leader: Schoppmann Seraina
AMG 355 20220028
Oct 17, 2024Eine Phase-1-Studie am Menschen zur Bewertung der Sicherheit, Verträglichkeit, Pharmakokinetik und Wirksamkeit von AMG 355 als Monotherapie und in Kombination mit Pembrolizumab bei Patienten mit fortgeschrittenen soliden Tumoren
Clinical Studies - Oct 17, 2024 - Dec 31, 2028
Ongoing
Project leader: Jörger Markus
Members: Donno Monica, Müller Fiona
SAKK 66/22 - Invincible 4 SAKK
Oct 17, 2024Protocol SAKK 66/22: Intratumoral INT230-6 followed by neoadjuvant immunochemotherapy in patients with early triple-negative breast cancer (TNBC). An openlabel randomized two-cohort phase 2 clinical trial. INVINCIBLE-4-SAKK
Clinical Studies - Oct 17, 2024 - Dec 31, 2029
Ongoing
Project leader: Jörger Markus
Members: Dei Cas Alissa, Müller Fiona
A comparison between the Swiss traffic perimetry (Swiss TPT) and the normal G2 strategy in automated perimetry: Observational cohort study
Oct 10, 2024Current Swiss visual requirements for driving are under re-evaluation. The present study aims to optimize visual field evaluation in daily practice to better differentiate between people who are fit to drive and those who are not.
Clinical Studies - Oct 10, 2024 - Oct 31, 2026
Ongoing
Project leader: Todorova Margarita
A multicenter, open-label, randomized, phase 2 study of venetoclax and azacitidine plus cusatuzumab versus venetoclax and azacitidine alone in newly diagnosed AML patients who are not candidates for intensive therapy
Oct 7, 2024
Clinical Studies - Oct 7, 2024 - Oct 9, 2028
Ongoing
Project leader: Schittenhelm Marcus
Members: Dei Cas Alissa
A phase 3 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of Amyloid Depleter ALXN2220 in adult participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Oct 1, 2024
Clinical Studies - Oct 1, 2024 - Dec 31, 2029
Scheduled
Project leader: Ehl Niklas
Members: Vetsch Susanne
MS201924_0002
Sep 30, 2024An open-label, multicenter, randomized Phase 2 study of the ATR inhibitor tuvusertib in combination with the PARP inhibitor niraparib or the ATM inhibitor lartesertib in participants with BRCA mutant and/or homologous recombination deficiency (HRD) p...
Clinical Studies - Sep 30, 2024 - Sep 30, 2028
Ongoing
Project leader: Huober Jens
Members: Dei Cas Alissa, Müller Fiona
Pulmonary Vein Isolation with Pulsed-Field Ablation with versus without Posterior wall ablation in Patients with Symptomatic Persistent Atrial Fibrillation
Sep 17, 2024A multicentre randomised clinical trial comparing two ablation strategies for the treatment of persistent AF (PVI only or PVI+ posterior wall ablation). IC: persistent AF, (N)OAK EC: atrial interventions, o. atrium >60mm, TAVI, Ml, >NYHA III, LVEF...
Clinical Studies - Sep 17, 2024 - Sep 17, 2027
Ongoing
Project leader: Franzeck Florian M
Members: Meier Jessica, Vetsch Susanne
A Phase 3, Open-label, Multicenter, Randomized Study of Tarlatamab in Combination With Durvalumab vs Durvalumab Alone in Subjects with Extensive-Stage Small-Cell Lung Cancer Following Platinum, Etoposide and Durvalumab (DeLLphi-305)
Aug 16, 2024
Clinical Studies - Aug 16, 2024 - Dec 31, 2099
Ongoing
Project leader: Früh Martin
Members: Hutter Franziska, Quinter Janine
A Randomized, Open-label, Phase 3 Trial of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in Treatment-naïve Subjects with Advanced or Metastatic PD-L1 High (TPS ≥50%) Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung08) (Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects with Advanced or Metastatic NSCLC Without Actionable Genomic Alterations)
Aug 13, 2024
Clinical Studies - Aug 13, 2024 - Dec 31, 2028
Ongoing
Project leader: Jörger Markus
Members: Harder Anja, Quinter Janine
Humoral immunity and risk factors for Alongshan-virus in healthcare workers from Eastern Switzerland –proposal for a seroepidemiologic analysis
Aug 1, 2024In dieser prospektiven Studie innerhalb der SURPRISE+ Kohorte möchten wir die Seroprävalenz und Serokonversion gegen das Alongshan-Virus (ALSV). ALSV ist ein Flavivirus, welches ein FSME-ähnliches Krankheitsbild auslösen kann. Das Virus wird häufig i...
Clinical Studies - Aug 1, 2024 - Feb 28, 2026
Ongoing
Project leader: Kohler Philipp
Members: Frischknecht Manuel, Kuster Stefan, Kahlert Christian